Pahilangco, Ardiano M.
HRN: 25-06-74 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/22/2024
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
05/22/2024
05/28/2024
IV
4.5
Q8h
Urosepsis
Waiting Final Action
Indication: Empiric Type of Infection: Urinary Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes